Atomic AI Company
At Atomic AI, we are developing the cutting-edge fusion of machine learning and structural biology to unlock RNA drug discovery. Our Platform Our proprietary platform leverages deep learning foundation models to discover and design RNAtargeted small molecules, RNAbased medicines, and RNA tools.
Investors
Connections from
Total Funding:
42000000.0
Headquarters:
United States
Funding Status:
Early Stage Venture
Employee Number:
11-50
Last Funding Type:
Series A
Technology:
['BioTech & HealthTech', 'Education, Research & SocialTech']
Last Funding Date:
2023-01-25
Investors Number:
14.0
Founded Date:
2020-01-01
Industry:
BioTech & Health Care